GLP-1 agonists for smoking cessation and post-cessation weight management: A systematic review and meta-analysis of randomized trials
Tobacco Induced Diseases · 26.07.2026 · 24 (July) · 1-12
DOI: 10.18332/tid/219815 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Tobacco Induced Diseases, online erschienen am 26.07.2026. Verfasst von Javad Heshmati und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Ottawa Heart Institute, Ottawa, Canada. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Ottawa Heart Institute, Ottawa, Canada.
- Ottawa Model for Smoking Cessation, Ottawa, Canada.
- Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Zitieren
APA
Heshmati, J., Mahmoodianfard, S., Raizman, E., Abraham, A., & Mir, H. (2026). GLP-1 agonists for smoking cessation and post-cessation weight management: A systematic review and meta-analysis of randomized trials. Tobacco Induced Diseases, 24(July), 1-12. https://doi.org/10.18332/tid/219815
Vancouver
Heshmati J, Mahmoodianfard S, Raizman E, Abraham A, Mir H. GLP-1 agonists for smoking cessation and post-cessation weight management: A systematic review and meta-analysis of randomized trials. Tobacco Induced Diseases. 2026;24(July):1-12. doi:10.18332/tid/219815
BibTeX
@article{Heshmati2026,
author = {Heshmati, Javad and Mahmoodianfard, Salma and Raizman, Ethan and Abraham, Aidan and Mir, Hassan},
title = {GLP-1 agonists for smoking cessation and post-cessation weight management: A systematic review and meta-analysis of randomized trials},
journal = {Tobacco Induced Diseases},
year = {2026},
volume = {24},
number = {July},
pages = {1--12},
doi = {10.18332/tid/219815}
}
EUVIMED